INT-0024

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameINT-0024
Drug Alias NameINT-0024/2010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntelgenx Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntelgenx Corp
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A